에 대한 최신 뉴스 Yerbae Brands (OTC:YERBF) 주식

Yerbae Brands Corp is a plant-based energy beverage company. It includes zero sugar, calories, or carbs and is powered by a natural caffeine source that uplifts without jitters, shakiness or a post-drink crash. The company delivers an enhanced experience that stimulates the body and focuses the mind without the jitters and crashes typically associated with energy drinks.

Wall Street

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

CASK

SEED

SHOT

YERBF

소비재 섹터에서 가장 과매도된 주식들은 저평가된 기업에 투자할 기회를 제공한다. 상대 강도 지수(RSI)는 주식이 상승하는 날과 하락하는 날의 강도를 비교하여 주식의 모멘텀을 나타내는 지표이다. 주식 가격 움직임과 비교하면, 단기적으로 주식이 어떻게 움직일지에 대한 더 나은 감각을 줄 수 있다. Benzinga Pro에 따르면, 일반적으로 RSI가 30 이하일 때 자산이 과매도 상태로 간주된다.

이번 분기에 폭발할 수 있는 최고 3개의 방어 주식

YERBAE BRANDS CORP by YERBAE BRANDS CORP.

Yerbae Brands Corp

President Donald Trump on Wednesday announced a slew of tougher-than-anticipated tariffs, but there are some <a href="https://www.whitehouse.gov/fact-sheets/2025/03/fact-sheet-president-donald-j-trump-addresses-the-threat-to-national-security-from-imports-of-timber-lumber-and-their-derivative-products/">notable exemptions</a> to the steep levies.&nbsp;
Here's a look at which products and sectors are excluded <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44626421/trumps-reign-of-tariffs-unleashes-d-day-on-wall-street-analyst-warns-of-stagflation-risk">from the reciprocal tariffs:&nbsp;</a>
Semiconductors: Semiconductors were exempted from the sweeping new tariffs due to their critical role in many technologies. However, the sector was deep in the red in Thursday's trading with shares of Broadcom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) down 6.78% and ASML Holding N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) down 3.69%.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/global/25/04/44628368/trumps-tariffs-prompt-china-to-vow-countermeasures-experts-see-retaliation-likely">Trump&#8217;s Tariffs Prompt China To Vow &#8216;Countermeasures&#8217;: Experts See Retaliation Likely&nbsp;</a>
Pharmaceuticals: Trump excluded pharmaceuticals from the new tariffs, likely a relief for the industry that had been under pressure following the president's prior comments suggesting a 25% tariff on pharmaceutical imports.&nbsp;
"The United States can no longer produce enough antibiotics to treat our sick," Trump said Wednesday. "We have a tremendous problem, we have to go to foreign countries to treat our sick. If anything ever happened from a war standpoint, we wouldn't be able to do it."
Pharmaceutical stocks are defying Thursday's broad market drop with shares of AbbVie Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) and Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) both in the green in mid-morning trading. 
Lumber: Lumber is another product excluded from Trump's tariff plan, for now. The administration said it is investigating how reliance on imported lumber impacts national security and economic stability. Exemptions have been granted to avoid immediate disruptions in supply chains critical to construction and defense in the meantime.&nbsp;
Gold, Copper: Certain metals and minerals including copper, gold and others not found in the U.S. were also exempted from the reciprocal tariff plan.&nbsp;
Gold dropped more than 3%, falling below $3,060 per ounce on Thursday after touching a new record high above $3,160. The SPDR Gold Trust ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), tracking the price of gold, was down only slightly, bucking the broader market declines.&nbsp;
Energy: Oil, gas and refined products imports were exempted from the sweeping new reciprocal tariffs, the White House said on Wednesday.&nbsp;
Shares of the United States Oil Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>) fell 7.8% on Thursday, however, as the sweeping tariff plan could threaten global demand.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/03/44537429/cathie-wood-doubles-down-on-2600-tesla-stock-price-prediction">Cathie Wood Doubles Down On $2,600 Tesla Stock Price Prediction</a></li>
</ul>
Photo: Shutterstock/Alones

Government

Specialty ETFs

Commodities

Politics

Global

Economics

Movers

Tech

ETFs

ABBV

ASML

AVGO

Trump's Tariff Exemptions Include Semiconductors, Pharmaceuticals, Oil And More

<a href="https://www.benzinga.com/news/25/03/44209579/unprecedented-slide-tesla-sales-plummet-45-in-europe-as-musks-net-worth-dives-5-2b-in-a-week">Tesla</a>'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) stock has taken a nosedive since President Donald Trump took office—but Elon Musk's privately held companies are on a wild upward ride.&nbsp;
Investors in secondary markets have driven up the combined valuation of four Musk-led companies by 45% since the Nov. 5 election, according to analysis from trading platform Caplight, as cited by <a href="https://www.bloomberg.com/news/articles/2025-03-12/musk-s-private-companies-soar-in-secondary-market-value-since-the-us-election?embedded-checkout=true">Bloomberg</a>.&nbsp;
The analysis relies on data from secondary transactions and market indicators, such as buyer interest, to provide daily share price estimates for SpaceX, Neuralink, The Boring Company, and xAI, reflecting strong investor confidence.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/startengine-own">The $1.3 billion startup investment boom: How this company's explosive growth is opening doors for everyday investors with a new $500 minimum</a></li>
<li><a href="https://www.benzinga.com/money/vatom-adv">Invest in the Future of Digital Engagement. Own a Piece of the $100 Billion Metaverse Today for Just $500.</a></li>
</ul>
<h2 class="wp-block-heading">Private Ventures Surging</h2>
Musk's artificial intelligence startup xAI has been the biggest driver of these gains. According to&nbsp; <a href="https://www.thetimes.com/business-money/companies/article/spacex-stock-elon-musk-worth-397cqgt89?msockid=0d686cb695db6f2a207779cd945e6e29">The Times of London</a> on Dec. 11, xAI reached a $50 billion valuation, nearly doubling its worth from six months ago, with the valuation occurring earlier in Dec.
​According to <a href="https://www.investopedia.com/elon-musk-xai-targets-usd75b-valuation-with-potential-usd10b-capital-raise-report-says-11680443">Investopedia</a>, xAI is planning to raise $10 billion from investors, which would increase its valuation to $75 billion. This potential funding round reflects growing interest in AI startups. It highlights xAI's rapid expansion as it competes with industry leaders in developing advanced AI technologies.
Shares of Neuralink, Musk's brain chip implant company, have also risen; they are trading at a valuation that is 25% higher as of March 11 compared to Nov. 5, according to Caplight, as cited by the <a href="https://nypost.com/2025/03/12/business/elon-musks-private-companies-xai-spacex-see-values-soar">New York Post</a>.
Trending: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.55 per share now</a>.
Recently, secondary market transactions suggest Neuralink&#8217;s valuation has reached approximately $9.32 billion, reflecting increased investor interest, as reported by <a href="https://www.bloomberg.com/news/articles/2025-03-12/musk-s-private-companies-soar-in-secondary-market-value-since-the-us-election">Bloomberg</a>. More than a third of Musk's wealth is tied up in his stake in rocket company SpaceX.&nbsp;
Despite Tesla's public share price struggles, SpaceX continues to attract buyers willing to pay a premium over its most recent tender offer price, according to Caplight CEO Javier Avalos, the Post said.&nbsp;
However, not all of Musk's ventures have experienced upward trends. According to the <a href="https://nypost.com/2025/03/12/business/elon-musks-private-companies-xai-spacex-see-values-soar/">Post</a>, The Boring Company, his tunnel-digging enterprise, saw a 7.8% decline in secondary market valuation since the election. Meanwhile, shares of Neuralink, his brain chip implant company, were 25% higher as of March 11 compared to Nov. 5, reinforcing a mixed picture across <a href="https://www.benzinga.com/startups/25/02/43483655/elon-musk-is-all-in-on-trump-tesla-investors-holding-600000-shares-question-if-he-can-still-run-a-1-25-trillion-company">Musk</a>'s portfolio.
See Also: <a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it">Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</a>
Despite challenges, investor interest in Musk's social media platform X remains strong. Although Caplight omitted X from its analysis due to "very limited" secondary market activity, <a href="https://www.bloomberg.com/news/articles/2025-02-19/musk-s-x-is-in-talks-to-raise-money-at-a-44-billion-valuation?sref=MTy2GeXk&amp;embedded-checkout=true">Bloomberg</a> reports that X was exploring new funding at a $44 billion valuation—the same amount Musk paid for the company when it was known as Twitter.&nbsp;
On March 28, <a href="https://x.com/elonmusk/status/1905731750275510312">Musk announced on X </a>that his AI company, xAI, acquired social-media platform X in an all-stock transaction. The deal values xAI at $80 billion and X at $33 billion.The move aims to integrate xAI&#8217;s advanced AI capabilities with X&#8217;s extensive user base, enhancing the platform&#8217;s innovation and user engagement, he said.&nbsp;
Read Next:
<ul>
<li>This platform is reshaping how you invest in private companies —<a href="https://www.benzinga.com/money/kingscrowd-adv"> and you can be a part of it for $0.18 per share</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
</ul>

TSLA

Musk's Boldest Move Yet? xAI Acquires X in a Game-Changing $80 Billion Deal—Here's Why Investors Are Paying Premiums

Whales with a lot of money to spend have taken a noticeably bearish stance on Exxon Mobil.
Looking at options history for Exxon Mobil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) we detected 20 trades.
If we consider the specifics of each trade, it is accurate to state that 45% of the investors opened trades with bullish expectations and 55% with bearish.
From the overall spotted trades, 16 are puts, for a total amount of $1,195,940 and 4, calls, for a total amount of $356,232.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $100.0 and $120.0 for Exxon Mobil, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Exxon Mobil options trades today is 3664.28 with a total volume of 10,170.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Exxon Mobil's big money trades within a strike price range of $100.0 to $120.0 over the last 30 days.
<h3>Exxon Mobil Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743697767_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>XOM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$3.4</td>
<td>$3.3</td>
<td>$3.4</td>
<td>$110.00</td>
<td>$306.0K</td>
<td>12.0K</td>
<td>1.9K</td>
</tr>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/02/25</td>
<td>$3.2</td>
<td>$3.15</td>
<td>$3.2</td>
<td>$115.00</td>
<td>$223.0K</td>
<td>816</td>
<td>19</td>
</tr>
<tr>
<td>XOM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$7.2</td>
<td>$7.2</td>
<td>$7.2</td>
<td>$110.00</td>
<td>$169.9K</td>
<td>5.1K</td>
<td>236</td>
</tr>
<tr>
<td>XOM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$2.95</td>
<td>$2.77</td>
<td>$2.76</td>
<td>$110.00</td>
<td>$121.2K</td>
<td>12.0K</td>
<td>996</td>
</tr>
<tr>
<td>XOM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/11/25</td>
<td>$0.69</td>
<td>$0.68</td>
<td>$0.68</td>
<td>$111.00</td>
<td>$108.8K</td>
<td>231</td>
<td>1.7K</td>
</tr>
</tbody>
</table>

<h3>About Exxon Mobil</h3>
ExxonMobil is an integrated oil and gas company that explores for, produces, and refines oil worldwide. In 2023, it produced 2.4 million barrels of liquids and 7.7 billion cubic feet of natural gas per day. At the end of 2023, reserves were 16.9 billion barrels of oil equivalent, 66% of which were liquids. The company is one of the world's largest refiners, with a total global refining capacity of 4.5 million barrels of oil per day, and is one of the world's largest manufacturers of commodity and specialty chemicals.
Having examined the options trading patterns of Exxon Mobil, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of Exxon Mobil</h3>
<ul>
<li>Currently trading with a volume of 8,876,468, the XOM's price is down by -4.02%, now at $113.9. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 0 days.</li>
</ul>
<h3>Expert Opinions on Exxon Mobil</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $134.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on Exxon Mobil with a target price of $135. 
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Overweight rating on Exxon Mobil with a target price of $138. 
&#x2A; Maintaining their stance, an analyst from Mizuho continues to hold a Neutral rating for Exxon Mobil, targeting a price of $129. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Exxon Mobil options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

Spotlight on Exxon Mobil: Analyzing the Surge in Options Activity

Investors with a lot of money to spend have taken a bullish stance on Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NKE, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 42 uncommon options trades for Nike.
This isn't normal.
The overall sentiment of these big-money traders is split between 42% bullish and 40%, bearish.
Out of all of the special options we uncovered, 24 are puts, for a total amount of $2,041,210, and 18 are calls, for a total amount of $1,352,735.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $45.0 to $82.5 for Nike over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Nike's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Nike's whale trades within a strike price range from $45.0 to $82.5 in the last 30 days. 
<h3>Nike Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743697762_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/17/27</td>
<td>$11.3</td>
<td>$9.95</td>
<td>$10.2</td>
<td>$65.00</td>
<td>$405.9K</td>
<td>601</td>
<td>483</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$4.65</td>
<td>$4.6</td>
<td>$4.65</td>
<td>$50.00</td>
<td>$345.0K</td>
<td>476</td>
<td>2.8K</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$10.9</td>
<td>$8.8</td>
<td>$8.8</td>
<td>$55.00</td>
<td>$312.4K</td>
<td>4.8K</td>
<td>537</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$10.0</td>
<td>$9.65</td>
<td>$9.65</td>
<td>$67.50</td>
<td>$206.5K</td>
<td>9.2K</td>
<td>325</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$9.1</td>
<td>$7.5</td>
<td>$7.5</td>
<td>$50.00</td>
<td>$147.0K</td>
<td>35</td>
<td>4</td>
</tr>
</tbody>
</table>

<h3>About Nike</h3>
Nike is the largest athletic footwear and apparel brand in the world. Key categories include basketball, running, and football (soccer). Footwear generates about two thirds of its sales. Its brands include Nike, Jordan (premium athletic footwear and clothing), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores, and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.
In light of the recent options history for Nike, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Nike Standing Right Now?</h3>
<ul>
<li>With a trading volume of 40,017,151, the price of NKE is down by -10.47%, reaching $58.16.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 84 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Nike</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $83.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Needham continues to hold a Buy rating for Nike, targeting a price of $80. 
&#x2A; Maintaining their stance, an analyst from Baird continues to hold a Outperform rating for Nike, targeting a price of $99. 
&#x2A; An analyst from JP Morgan has decided to maintain their Neutral rating on Nike, which currently sits at a price target of $64. 
&#x2A; An analyst from BMO Capital has decided to maintain their Outperform rating on Nike, which currently sits at a price target of $92. 
&#x2A; Consistent in their evaluation, an analyst from Telsey Advisory Group keeps a Market Perform rating on Nike with a target price of $80. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Nike with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Smart Money Is Betting Big In NKE Options

ServiceNow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) has <a href="https://www.benzinga.com/pressreleases/25/04/b44626182/servicenow-to-boost-crm-offering-with-acquisition-of-logik-ais-best-in-class-ai-powered-cpq-soluti">acquired Logik.ai, a company specializing in AI-powered </a>Configure, Price, Quote (CPQ) solutions. 
The deal is expected to bolster ServiceNow's presence in Customer Relationship Management (CRM) and streamline sales and order management processes.
By integrating Logik.ai's technology, ServiceNow aims to simplify complex sales cycles, enhance productivity and improve efficiency for businesses across various industries.
Industries such as high-tech manufacturing and medical devices often struggle with inefficient sales processes caused by complex product setups and outdated pricing structures.
Also Read: <a href="https://www.benzinga.com/25/04/44624263/netflix-expands-language-options-for-tv-viewers">Netflix Rolls Out Enhanced Subtitle &amp; Dubbing Options On TV</a>
Logik.ai's AI-powered CPQ solution aims to resolve these challenges by streamlining transaction workflows, minimizing errors, and speeding up deal finalization.
The acquisition of Logik.ai is expected to strengthen ServiceNow CRM and Industry Workflows segment, which is already ServiceNow&#8217;s fastest-growing business.
The integration will introduce AI-powered selling tools that refine quoting, order placement, and fulfillment processes.
Logik.ai's modular CPQ platform accommodates various sales channels, such as business-to-business, partner networks, and self-service for consumers. 
Currently, Logik.ai is compatible with nearly 50 technology partners, including ServiceNow. The acquisition is subject to customary regulatory approvals and closing conditions. 
Details of the transaction were not disclosed. ServiceNow <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001373715/000137371525000010/now-20241231.htm">held $2.3 billion in cash and equivalents</a> as of Dec. 31, 2024.
NOW Price Action: ServiceNow shares traded lower by 5.09% at $782 at publication Thursday.
Read Next: <a href="https://www.benzinga.com/news/25/04/44605217/phoenix-motor-and-inductev-power-up-ev-fleets-with-wireless-charging-tech">Phoenix Motor And InductEV Power Up EV Fleets With Wireless Charging Tech</a>
Photo: Shutterstock

Fintech news covering the emerging Financial Technology services sector

Fintech

ServiceNow Supercharges Sales Strategy With Logik.ai Acquisition

Legal

Capital One Deal For Discover Clears Justice Department Hurdle

Market analysts say President Donald Trump's newly announced global tariff regime is already reshaping investor sentiment, triggering sharp corrections <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44625640/anthony-pompliano-praises-trumps-tariffs-as-catalyst-for-crypto-innovation">across risk assets—including crypto. </a>
While digital currencies initially showed some resilience, experts caution that they remain exposed to broader macroeconomic shocks.
Trump's April 2 speech, which introduced a "reciprocal tariff" program with baseline rates starting at 10% and scaling up to 50% by April 9, caused immediate <a href="https://www.benzinga.com/25/04/44622346/trumps-reciprocal-tariff-math-a-masterclass-in-economic-absurdity">volatility in financial markets</a>.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) has dipped below $82,000, while U.S. equity futures and global ETFs slid.
Trump described the move as a "Declaration of Economic Independence," aimed at rebalancing global trade dynamics.
According to David Hernandez, a crypto investment specialist at 21Shares, the tariffs removed some ambiguity around U.S. trade policy but raised new concerns. 
"Markets thrive on clarity, and now that the scope is known, we may see institutions buy the dip," he said. "Still, the announcement rattled equities and crypto alike. Bitcoin held above key support at $82,000 but couldn't avoid broader risk-off pressure."
James Toledano, COO at Unity Wallet, observed that crypto wasn't immune to the impact. 
"Bitcoin is down 4.9% on the week, holding around $82,000," he said. "This shows that in the early stages of global instability, digital assets behave more like tech stocks than safe havens."
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44628685/bitcoin-is-a-realistic-global-reserve-asset-experts-say">Bitcoin Is A Realistic Global Reserve Asset, Experts Say</a>
Toledano added that if the situation escalates into a prolonged economic standoff, crypto could gain renewed appeal. "We're not at safe haven status yet, but if confidence in fiat wavers, Bitcoin might decouple over time."
Javier Rodriguez-Alarcon, Chief Commercial Officer at XBTO, echoed that view, noting the correlation between Bitcoin and traditional markets during moments of high volatility. "Bitcoin still trades like a risk asset during policy shocks. That doesn't negate its long-term potential, but the narrative as a hedge is still maturing."
He added that as digital assets gain wider institutional traction, future dislocations may see crypto react differently. 
For now, however, "the sell-off shows crypto is still subject to the same sentiment-driven dynamics that move traditional finance."
Despite these headwinds, Hernandez noted that institutional inflows into Bitcoin ETFs remained steady, suggesting some investors may view the dip as an entry point. 
"The market reaction underscores Bitcoin's borderless appeal in hedging against geopolitical uncertainty," he said.
With key U.S. trading partners expected to respond in the coming days, including China, South Korea, and Mexico, analysts say further volatility is likely across all asset classes—crypto included.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44627407/gold-overtaking-bitcoin-in-inflation-hedge-strategy-jpmorgan-says">Gold Overtaking Bitcoin In Inflation Hedge Strategy, JPMorgan Says</a></li>
</ul>
Image created using artificial intelligence with Midjourney.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin As Trump Tariff Safe Haven? Not Yet, But 'Might Decouple Over Time,' Expert Says

Dutch advanced chipmaking equipment supplier ASML Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) plans to quintuple its Japan-based maintenance staff for the machines in the next few years, Nikkei <a target="_blank" href="https://asia.nikkei.com/Business/Tech/Semiconductors/ASML-to-quintuple-advanced-EUV-chip-tools-staff-in-Japan" rel="noreferrer noopener">reported</a> Tuesday.
ASML manufactures extreme ultraviolet (EUV) lithography equipment for making advanced technology chips.
In December, Rapidus became the first Japanese chipmaker to receive EUV machines.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43945751/huawei-boosts-ai-chip-production-despite-taiwan-semi-and-asml-ban-aims-to-challenge-nvidia-in-china" rel="noreferrer noopener">Huawei Boosts AI Chip Production Despite Taiwan Semi And ASML Ban, Aims to Challenge Nvidia In China</a>
Japan continues bolstering its advanced semiconductor technology position, as in the U.S., Europe, and China.
Japanese multinational investment holding company Softbank Group Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBY#OTC">SFTBY</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBF#OTC">SFTBF</a>) is <a target="_blank" href="https://www.benzinga.com/media/25/04/44589685/softbank-weighs-165-billion-loan-that-could-back-openais-40-billion-raise-report" rel="noreferrer noopener">weighing a loan</a> of up to $16.5 billion to finance its&nbsp;U.S. artificial intelligence ambitions. The loan may help SoftBank lead a $40 billion&nbsp;funding round&nbsp;in OpenAI. The move values the ChatGPT parent&nbsp;at $300 billion.
Contract chipmaker Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) is expanding globally with <a target="_blank" href="https://www.benzinga.com/government/regulations/25/01/42843001/taiwan-semiconductor-ramps-up-production-in-japan-us-and-germany-to-diversify-away-from-china" rel="noreferrer noopener">plants in the U.S., Japan, and Germany</a>.
Meanwhile, ASML continues to gain traction, which is backed by the higher demand for semiconductor chips.
In March, ASML and imec forged a <a target="_blank" href="https://www.benzinga.com/markets/eurozone/25/03/44253751/asml-boosts-ai-chip-rd-in-europe-amid-us-sanctions-china-slowdown-and-subsidy-uncertainty" rel="noreferrer noopener">five-year deal</a> complemented by funding made available by the Chips Joint Undertaking, the Flemish government, and&nbsp;the Dutch government to boost semiconductor R&amp;D and sustainable innovation with EU and government backing to develop sub-2nm chips and advance AI-ready semiconductor solutions.
ASML Holding stock has plunged 34% in the last 12 months. The company disclosed in its&nbsp;annual report that the U.S. semiconductor sanctions on China hurt 2024 demand, with China making up 36% of its sales.
ASML customers slashed capital spending amid U.S. chip restrictions, impacting AI and semiconductor growth. Additionally, reports indicated President Donald Trump&#8217;s plans to scrap&nbsp;the U.S. CHIPS Act.
The EUV lithography market size was worth $10.09 billion in 2023 and is <a target="_blank" href="https://www.globenewswire.com/news-release/2025/03/21/3047088/0/en/Extreme-Ultraviolet-EUV-Lithography-Market-to-Hit-USD-35-70-billion-by-2032-Driven-by-Rising-Demand-for-Advanced-Semiconductor-Manufacturing-SNS-Insider.html" rel="noreferrer noopener">expected to reach</a> $35.70 Billion by 2032 and grow at a CAGR of 15.1% over the forecast period 2024-2032.
The growth potential reflects technological advancements, increasing semiconductor complexity, and the demand for smaller, more powerful chips. Industries like AI, high-performance computing, 5G, and IoT.
Price Action:&nbsp;ASML stock is down 4.55% at $638.55 at the last check on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43938789/intel-deploys-asmls-advanced-euv-machines-aims-to-challenge-taiwan-semiconductors-lead" target="_blank" rel="noreferrer noopener">Intel Deploys ASML&#8217;s Advanced EUV Machines, Aims to Challenge Taiwan Semiconductor&#8217;s Lead</a></li>
</ul>
Photo via Shutterstock

Asia

Media

SFTBF

SFTBY

Chip Equipment Maker ASML To Boost Japan Workforce 5x Amid Global Race For Advanced Semiconductor Tech

OTIS

Live On CNBC: Josh Brown Buys OTIS

KinderCare Learning Companies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KLC#NYSE">KLC</a>) is under fire Thursday following a <a href="https://thebearcave.substack.com/p/problems-at-kindercare-learning-companies">new report</a> from The Bear Cave, which alleges safety failures, regulatory concerns and a deteriorating reputation at the nation's <a href="https://www.benzinga.com/quote/KLC">largest private childcare provider</a>.
What Happened: The Bear Cave released a short report on KinderCare Thursday, alleging the company is plagued by operational failures that could threaten its stock performance.
"Recent investigations reveal alarming safety incidents, including children left unsupervised, instances of abuse and regulatory violations that raise serious concerns about KinderCare's ability to operate responsibly," the short seller said.
Benzinga has reached out to KinderCare Learnings Companies for comment on the report.
Read Also: <a href="https://www.benzinga.com/trading-ideas/technicals/25/04/44629335/apple-stock-slammed-by-trump-tariffs-is-a-death-cross-next">Apple Stock Slammed By Trump Tariffs: Is A Death Cross Next?</a>
KinderCare operates roughly 1,500 childcare centers across 41 states and relies heavily on government funding. The company went public in 2022, positioning itself as a leader in early childhood education.
The Bear Cave&#8217;s report cites troubling incidents, including a <a href="https://www.jsonline.com/story/communities/south/2024/11/20/cudahy-woman-pleads-guilty-in-oak-creek-kindercare-cocaine-case/76434101007/">case</a> where an 11-month-old tested positive for cocaine at a KinderCare center in Wisconsin. Other reports detail children <a href="https://wcti12.com/news/local/teachers-on-leave-after-toddler-wanders-onto-busy-road-from-daycare">escaping</a> facilities, being <a href="https://www.nbcnews.com/news/us-news/florida-mom-finds-toddler-locked-day-care-workers-left-day-rcna16918">locked</a> inside after closing hours and experiencing mistreatment by staff.
&#8220;In sum, The Bear Cave believes KinderCare is a broken business that harms the children and families it claims to help,&#8221; the short seller said.
The Bear Cave reported that KinderCare has faced repeated scrutiny from regulatory agencies. The short seller believes growing concerns could impact its ability to secure funding and expand operations.
The short seller also highlighted online complaints from parents and former employees, with some alleging understaffing, inadequate training and neglect.
KLC Price Action: <a href="http://benzinga.com/quote/klc">KinderCare shares</a> are falling by 10.8 % during Thursday&#8217;s session, trading at $11.40 at the time of publication. According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, KinderCare has a 52-week high of $29.89 and a 52-week low of $10.91 after making new lows for the year in Thursday&#8217;s session.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/25/04/44628368/trumps-tariffs-prompt-china-to-vow-countermeasures-experts-see-retaliation-likely" target="_blank" rel="noreferrer noopener">Trump's Tariffs Prompt China To Vow ‘Countermeasures': Experts See Retaliation Likely</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/lordn">Lordn</a>/Shutterstock.

Short Sellers

Short Ideas

Short Seller Slams KinderCare Over Safety Failures, Stock Hits New 52-Week Low

WIIM

ACDC

CGBS

CIVI

EQNR

FANG

SHEL

Shares of energy companies are trading lower as markets react to President Trump's announcement of sweeping tariffs.

Truist Securities analyst William Stein maintains Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) with a Hold and lowers the price target from $373 to $280.

Price Target

Analyst Ratings

Truist Securities Maintains Hold on Tesla, Lowers Price Target to $280

TIVC

Tivic Health Shares resume Trading

Tivic Health Shares Halted On Circuit Breaker To Downside; Stock Up 53.9%

Genius Group Ltd (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GNS#AMEX">GNS</a>) shares are trading lower on Thursday following news that the company is being compelled <a href="https://www.benzinga.com/pressreleases/25/04/g44625455/genius-group-blocked-from-raising-funds-and-buying-bitcoin-by-new-york-court" target="_blank" rel="noreferrer noopener">to sell its Bitcoin treasury.</a>
The move comes after a court ruling in the U.S. District Court Southern District of New York, which blocked Genius from selling shares, raising funds and using investor money to purchase Bitcoin.
This injunction was granted as part of a larger legal battle with Fatbrain AI, part of Lzg International Inc (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LZGI#OTC">LZGI</a>), where Genius had initiated arbitration to terminate its asset purchase agreement with the company.
The court&#8217;s decision is based on fraud allegations against LZGI executives Michael Moe and Peter Ritz, who have been accused of defrauding shareholders.
Also Read: <a target="_blank" href="https://www.benzinga.com/top-stories/25/04/44627817/retaliation-odds-spike-after-trumps-heavy-tariffs-sending-country-etfs-tumbling" rel="noreferrer noopener">Retaliation Odds Spike After Trump&#8217;s Heavy Tariffs, Sending Country ETFs Tumbling</a>
Genius filed motions and presented evidence of what it claims is a scheme to extort money from the company through the legal process.
As a result, Genius&#8217;s ability to finance its operations and issue share compensation to employees has been blocked, forcing the company to consider drastic measures.
In response, Genius is actively appealing the injunction, while restructuring its operations, including downsizing and halting marketing and investment activities.
The company has been forced to sell some of its Bitcoin holdings to sustain operations, reducing its treasury from 440 Bitcoin to 430 Bitcoin.
Despite the challenges, CEO Roger James Hamilton remains committed to fighting fraud and market manipulation and intends to protect shareholders&#8217; interests.
The ongoing restrictions, however, pose a serious risk to the company's future operations, with Genius&#8217; stock price falling 53% since the temporary restraining order was imposed.
GNS Price Action: Genius shares are trading lower by 11.88% to 22 cents at publication Thursday.
Read Now:
<ul>
<li><a href="https://www.benzinga.com/25/04/44624245/tariffs-to-plug-the-hole-for-income-tax-cuts-to-come-economists-predict-what-more-could-be-expected" target="_blank" rel="noreferrer noopener">Trump Tariffs To ‘Plug The Hole' For Income Tax Cuts To Come: Economists Predict What More Could Be Expected</a></li>
</ul>
Photo: Courtesy Genius Group

General

LZGI

What's Going On With Genius Group Stock Today?

CART

CASY

CELH

CHEF

COST

HNST

PFGC

USFD

Shares of companies within the broader consumer staples sector are trading lower as markets react to President Trump's announcement of sweeping tariffs.

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dipping more than 800 points on Thursday.
The Dow traded down 3.07% to 40,929.87 while the NASDAQ fell 4.83% to 16,750.33. The S&amp;P 500 also fell, dropping, 3.73% to 5,459.39.
Check This Out: <a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44625270/top-3-tech-and-telecom-stocks-youll-regret-missing-this-month">Top 3 Tech And Telecom Stocks You&#8217;ll Regret Missing This Month</a>
Leading and Lagging Sectors Consumer staples shares rose by 0.4% on Thursday.
In trading on Thursday, energy shares tumbled by 5.6%.
Top Headline
The ISM services PMI dipped to 50.8 in March versus a reading of 53.5 in February, and down from market estimates of 53.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Lamb Weston Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) shares shot up 10% to $59.60 after the company reported better-than-expected third-quarter financial results and issued FY25 sales guidance above estimates.</li>
<li>Shares of NewGenIvf Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>)got a boost, surging 95% to $1.15 after the company announced it secured $5.2 million in funding to drive international expansion.</li>
<li>The Goodyear Tire &amp; Rubber Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GT#NASDAQ">GT</a>) shares were also up, gaining 12% to $10.19.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Aldeyra Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALDX#NASDAQ">ALDX</a>) shares dropped 76% to $1.2750 after the company received a response letter from the FDA for the Reproxalap new drug application for the treatment of signs and symptoms of dry eye disease.</li>
<li>Shares of RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) were down 41% to $147.59 after the company reported weaker-than-expected fourth-quarter financial results.</li>
<li>Wayfair Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) was down, falling 22% to $26.30. Shares of specialty retailers in the furniture and home goods space traded lower following disappointing earnings from RH.</li>
</ul>
Commodities In commodity news, oil traded down 7.1% to $66.64 while gold traded down 1.8% at $3,110.80.
Silver traded down 7.1% to $32.205 on Thursday, while copper fell 3.4% to $4.8705.
Euro zone
European shares were lower today. The eurozone's STOXX 600 fell 2.19%, Germany's DAX 40 dipped 2.11% and France's CAC 40 fell 2.93%. Spain's IBEX 35 Index fell 1.32%, while London's FTSE 100 fell 1.30%.
Asia Pacific Markets
Asian markets closed lower on Thursday, with Japan's Nikkei 225 dipping 2.77%, China's Shanghai Composite Index falling 0.24%, Hong Kong's Hang Seng Index falling 1.52% and India's BSE Sensex falling 0.42%.
Economics
<ul>
<li>U.S. initial jobless claims fell by 6,000 to 219,000 in the week ending March 29, compared to market estimates of 225,000.</li>
<li>The U.S. trade deficit shrank to $122.7 billion in February compared to $130.7 billion in the previous month and versus market estimates of a $123.5 billion gap.</li>
<li>The S&amp;P Global services PMI was revised higher to 54.4 in March compared to a preliminary reading of 54.3.</li>
<li>The S&amp;P Global composite PMI climbed to 53.5 in March versus 51.6 in the previous month.</li>
<li>The ISM services PMI dipped to 50.8 in March versus a reading of 53.5 in February, and down from market estimates of 53.</li>
</ul>
Now Read This:
<ul>
<li> <a href="https://www.benzinga.com/news/earnings/25/04/44622367/acuity-rh-and-3-stocks-to-watch-heading-into-thursday">Acuity, RH And 3 Stocks To Watch Heading Into Thursday</a> </li>
</ul>
Photo via Shutterstock

Earnings

Equities

Eurozone

Intraday Update

ALDX

NIVF

Crude Oil Dips 7%; ISM Services PMI Falls In March

Macro Economic Events

Econ #s

Canada PM Carney Says: He May Speak With Trump Again But Nothing Scheduled

PAAS

Shares of precious metals stocks are trading lower as markets react to President Trump's announcement of sweeping tariffs.

The U.S. Food and Drug Administration (FDA) on Wednesday granted accelerated approval for Novartis AG&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>) Vanrafia (atrasentan) to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">rapid disease progression</a>.
Vanrafia is a once-daily, non-steroidal, oral treatment that can be added to supportive care, including a renin-angiotensin system inhibitor with or without a sodium-glucose co-<a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n44619827/novartis-receives-fda-accelerated-approval-for-vanrafia-atrasentan-the-first-and-only-selective-en" rel="noreferrer noopener">transporter-2 inhibitor</a>.
Vanrafia was granted accelerated approval based on a prespecified interim analysis of the Phase 3 ALIGN study measuring the reduction of proteinuria at 36 weeks compared to placebo.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44592342/apellis-pharmaceuticals-rare-kidney-disease-drug-under-fda-review-seeks-to-compete-novartis-recently-approved-drug" rel="noreferrer noopener">FDA Reviews Kidney Disease Drug From Apellis Pharmaceuticals</a>
It has not been established whether Vanrafia slows kidney function decline in patients with IgAN.
The continued approval of Vanrafia may be contingent upon verifying clinical benefit from the ongoing Phase 3 ALIGN study evaluating whether Vanrafia slows disease progression as measured by estimated glomerular filtration rate (eGFR) decline at week 136.
The eGFR data are expected in 2026 and are intended to support traditional FDA approval.
In the ongoing Phase 3 ALIGN study, patients receiving Vanrafia in combination with a RAS inhibitor achieved clinically meaningful and statistically significant proteinuria reduction of 36.1% compared to placebo, with results seen as early as week 6 and sustained through week 36.
A similar treatment effect of Vanrafia was seen in an additional group of patients treated with both an RAS inhibitor and an SGLT2 inhibitor (37.4% reduction in UPCR vs. placebo).
The ALIGN study showed that Vanrafia has a favorable safety profile consistent with previously reported data.
This is Novartis&#8217;s third U.S. approval for its kidney disease portfolio in the last year. Fabhalta&nbsp;was granted FDA approval in <a target="_blank" href="https://www.benzinga.com/general/biotech/25/03/44544720/fda-oks-novartis-prostate-cancer-treatment-triples-eligible-patient-pool" rel="noreferrer noopener">C3 glomerulopathy in&nbsp;March 2025</a> and accelerated approval in <a target="_blank" href="https://www.benzinga.com/general/biotech/24/08/40254535/fda-approves-expanded-use-of-novartis-rare-disease-drug-fabhalta-for-kidney-disease" rel="noreferrer noopener">IgAN in&nbsp;August 2024</a>.
Fabhalta is also being studied in rare kidney diseases, including atypical hemolytic uremic syndrome, immune complex membranoproliferative glomerulonephritis, and lupus nephritis.
An investigational subcutaneously administered anti-APRIL monoclonal antibody, zigakibart, is currently in Phase 3 development in IgAN, with results expected in 2026.
Price Action: NVS stock is up 2.16% at $113.17 at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/04/44614171/uks-health-agency-endorses-pfizers-blood-cancer-combo-therapy-as-first-for-untreated-hodgkin-lymphoma-patients" target="_blank" rel="noreferrer noopener">UK&#8217;s Health Agency Endorses Pfizer&#8217;s Blood Cancer Combo Therapy As First For Untreated Hodgkin Lymphoma Patients</a></li>
</ul>
Photo by Taljat David via Shutterstock

Biotech

Health Care

Novartis Secures Third FDA Approval For Its Kidney Disease Portfolio In One Year

Press Releases

Safety Shot to Acquire Yerbaé Brands Corp., adding approximately $12 Million to Annual Revenue and Creating a Potential Force in Wellness and Functional Beverages

Small Cap

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Yerbaé Brands Corp. - YERBF

YERBAÉ BRANDS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Yerbaé Brands Corp. - YERBF

Yerbaé Expands Distribution with Four New Partnerships, Creating Synergies with Safety Shot's Operations

Yerbae Expands Midwest Convenience Store Presence with Casey's General Stores Authorization

YERBAÉ BRANDS CORP. ANNOUNCES LOAN AGREEMENT WITH MAXIMCASH

Safety Shot, Inc. Terminates At-the-Market Equity Offering, Reaffirms Strong Financial Position and Growth Trajectory

Yerbae Expands Colorado Distribution Through Eagle Rock Distributing and King Soopers, Seeking to Mirror Safety Shot's Success in Major Supermarket Chains

Yerbaé Expands Georgia Distribution Through Savannah Distributing Company Inc. and Announces Grant of Equity Incentives

Safety Shot CEO Jarrett Boon and Yerbaé CEO Todd Gibson Join FORCE Family Webinar to Discuss How Safety Shot Plans to Disrupt the Functional Wellness and Beverage Market

SHOTW

TSXV:YERB

TSXV:YERB-U.V

TSXV:YERB.U

Yerbae Brands

Roth MKM

소비재 섹터에서 가장 과매도된 주식들은 저평가된 기업에 투자할 기회를 제공한다.
상대 강도 지수(RSI)는 주식이 상승하는 날과 하락하는 날의 강도를 비교하여 주식의 모멘텀을 나타내는 지표이다. 주식 가격 움직임과 비교하면, 단기적으로 주식이 어떻게 움직일지에 대한 더 나은 감각을 줄 수 있다. <a href="https://www.benzinga.com/topic/rsi">Benzinga Pro</a>에 따르면, 일반적으로 RSI가 30 이하일 때 자산이 과매도 상태로 간주된다.
소비재 섹터에서 RSI가 30 근처이거나 30 이하인 주요 과매도 주식의 최신 목록은 다음과 같다.
<h3 class="wp-block-heading">오리진 애그리테크 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEED#NASDAQ">SEED</a>)</h3>
<ul>
<li>2024년 8월 23일, 오리진 애그리테크(Origin Agritech)는 얀 웨이빈(Weibin Yan)을 CEO로 임명했다. 회사의 주가는 지난 한 달 동안 약 20% 하락했으며, <a href="https://www.benzinga.com/quote/SEED">52주 최저가가 $1.37</a>이다.</li>
<li>RSI 값: 27</li>
<li>SEED 주가 움직임: 오리진 애그리테크의 주식이 금요일 변동없이 $1.83에 마감했다.</li>
<li>Benzinga Pro의 실시간 뉴스피드가 <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011725&amp;t=be2bearmibe3na1">SEED 뉴스</a>를 최신으로 알렸다.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011725&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" class="wp-image-738445" style="width: 669px; height: auto;" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/17040552/image-115.png" sizes="(max-width: 920px) 100vw, 920px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/17040552/image-115.png 920w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/17040552/image-115-300x273.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/17040552/image-115-768x700.png 768w" alt="" width="920" height="838" /></a></figure>
<h3 class="wp-block-heading">세이프티 샷 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOT#NASDAQ">SHOT</a>)           </h3>
<ul>
<li>2024년 1월 8일, 세이프티 샷(Safety Shot)과 식물 기반 음료 제조업체인 예르바에 브랜즈(OTC:<a class="ticker" href="https://www.benzinga.com/stock/YERBF#OTC">YERBF</a>)가 합병 계약을 최종화했다. 이 거래는 세이프티 샷의 웰니스 제품과 예르바에(Yerbaé)의 식물 기반 에너지 음료를 통합하여 시장 성장을 가속화하고 두 회사의 존재감을 강화할 것으로 예상된다. 회사의 주가는 지난 5일 동안 약 14% 하락했으며, <a href="https://www.benzinga.com/quote/SHOT">52주 최저가가 $0.51</a>이다.</li>
<li>RSI 값: 28.7</li>
<li>SHOT 주가 움직임: 세이프티 샷의 주식이 금요일 3.72% 하락 $0.54에 마감했다. 이후 시간외 거래에서 2.91% 상승했다.</li>
<li>Benzinga Pro의 차트 도구가 <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011725&amp;t=be2bearmibe3na1">SHOT 주식</a>의 추세를 식별하는 데 도움을 주었다.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011725&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" class="wp-image-738446" style="width: 548px; height: auto;" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/17040622/image-116.png" sizes="(max-width: 927px) 100vw, 927px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/17040622/image-116.png 927w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/17040622/image-116-300x273.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/17040622/image-116-768x698.png 768w" alt="" width="927" height="843" /></a></figure>
<h3 class="wp-block-heading">헤리티지 디스틸링 홀딩 컴퍼니 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CASK#NASDAQ">CASK</a>)</h3>
<ul>
<li>2024년 12월 31일, 헤리티지 디스틸링 홀딩 컴퍼니(Heritage Distilling Company)는 마이클 P. 카로시노(Michael P. Carrosino)를 CFO로 임명했다. HDC의 CEO 저스틴 스티펠(Justin Stiefel)은 &#8220;우리는 마이클이 헤리티지에 새로운 CFO로 합류하게 되어 매우 기쁘다. 그의 여러 산업에서의 인상적인 실적과 회계, 재무 운영 및 상장 회사 경험이 우리의 리더십 팀과 기업 구조를 강화할 것이다&#8221;고 언급했다. 이 회사의 주가는 지난 한 달 동안 약 47% 하락했으며, 52주 <a href="https://www.benzinga.com/quote/CASK">최저가가 $1.05</a>입니다.</li>
<li>RSI 값: 23.4</li>
<li>CASK 주가 움직임: 헤리티지 디스틸링 홀딩 컴퍼니의 주식이 금요일에 변동없이 $1.23에 마감했다. 이후 시간외 거래에서 5.68% 상승했다.</li>
<li>Benzinga Pro의 신호 기능이 <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011725&amp;t=be2bearmibe3na1">CASK 주식</a>의 잠재적 돌파구를 알렸다.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011725&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" class="wp-image-738448" style="width: 563px; height: auto;" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/17040721/image-117.png" sizes="(max-width: 875px) 100vw, 875px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/17040721/image-117.png 875w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/17040721/image-117-300x288.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/17040721/image-117-768x737.png 768w" alt="" width="875" height="840" /></a></figure>
다음으로 읽어야 할 것:
<ul>
<li><a href="https://www.benzinga.com/25/01/43025282/wall-streets-most-accurate-analysts-views-on-3-energy-stocks-with-over-7-dividend-yields">월스트리트의 가장 정확한 애널리스트들이 7% 이상의 배당 수익률을 가진 3개의 에너지 주식에 대한 견해</a></li>
</ul>
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Yerbae Brands

뉴스

에 대한 최신 뉴스 Yerbae Brands (OTC:YERBF) 주식

금요일, 1월 17, 2025

뉴스

파트너 / 기고자

벤징가 글로벌